0000899243-20-023369.txt : 20200825
0000899243-20-023369.hdr.sgml : 20200825
20200825163050
ACCESSION NUMBER: 0000899243-20-023369
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200825
FILED AS OF DATE: 20200825
DATE AS OF CHANGE: 20200825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hall Steven Edward
CENTRAL INDEX KEY: 0001602732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 201132618
MAIL ADDRESS:
STREET 1: 15001 BARNHARDT CT
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-25
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001602732
Hall Steven Edward
C/O LILLY VENTURES
333 N. ALABAMA ST., SUITE 350
INDIANAPOLIS
IN
46204
1
0
0
0
Common Stock
2020-08-25
4
C
0
2192249
A
2192249
I
See Footnote
Series A Convertible Preferred Stock
2020-08-25
4
C
0
2511198
0.00
D
Common Stock
1574517
0
I
See Footnote
Series B Convertible Preferred Stock
2020-08-25
4
C
0
985220
0.00
D
Common Stock
617732
0
I
See Footnote
Represents the total number of shares of common stock received upon the conversion of the Issuer's preferred stock in connection with the closing of the Issuer's initial public offering.
All series of preferred stock automatically converted into the Issuer's common stock on a one-for-1.5949 basis upon the closing of the Issuer's initial public offering and had no expiration date.
These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which includes the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
/s/ Bruce N. Jacobs, as Attorney-in-Fact
2020-08-25